ArticleACTRIMS 2021: Safety and efficacy of disease-modifying therapies in multiple sclerosisAuthor:Mark S. Freedman, MSc, MDPublish date: March 19, 2021Mark S. Freedman, MSc, MD, summarizes abstracts on D...Read More
ArticleHighlights on Treatment of Progressive MS From ECTRIMS 2020Author:Mark S. Freedman, MSc, MDPublish date: October 13, 2020Dr Mark Freedman reports on key findings in progressive MS from ECTRIMS 2020, in...Read More
ArticleECTRIMS 2020 Highlights: Managing RRMS, Symptoms in the Time of COVID-19Author:Mark S. Freedman, MSc, MDPublish date: October 13, 2020Dr Mark Freedman discusses new data on managing fatigue in patients with RRMS and highlights guidelines for RRMS treatment during the COVID-19 pand...Read More
